Efficacy and safety of the PD-1 inhibitor prolgolimab in combination with bendamustine as a second-line salvage regimen in patients with classic Hodgkin lymphoma

作者：Liudmila Fedorova, Polina Kotselyabina, Кирилл Лепик, Andrey Chekalov, Vladislav Markelov, Valeria Shpirko, Anastasia Semenova, Gayane Tumyan, Stanislav Volchenkov, Angelina Piletskaya, Ilya Zyuzgin, Natalia Konoply, Alexander Kulagin · 发表于：Cellular Therapy and Transplantation · 年份：2026 · DOI：10.18620/ctt-1866-8836-2026-15-2-20-27 · 研究领域：Lymphoma Diagnosis and Treatment、Cancer Immunotherapy and Biomarkers、HER2/EGFR in Cancer Research